Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FDA Accepts GW Pharma's Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet…

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

The PDUFA goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018. Source: BioSpace

Continue ReadingFDA Accepts GW Pharma's Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet…

4 Top-Performing S&P 500 Biotech Stocks of 2017

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

It was a pretty good year for the stock market, but how about for biotech stocks? Source: BioSpace

Continue Reading4 Top-Performing S&P 500 Biotech Stocks of 2017

Keryx, Norwich Pharma Mutually Terminate Manufacturing Agreement

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

The deal was originally inked on Jan 17, 2014‍​. Source: BioSpace

Continue ReadingKeryx, Norwich Pharma Mutually Terminate Manufacturing Agreement

Fresenius SE Allegedly Ignored Hundreds of Bad Quality Tests at Plant in India

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

The agency inspected the plant from May 15 to May 24, 2017, and observed that staffers at the plant were basically gaming the quality control system. Source: BioSpace

Continue ReadingFresenius SE Allegedly Ignored Hundreds of Bad Quality Tests at Plant in India

Shareholders Turn Down Tender Offer to Take BioCanCell Private

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace

Continue ReadingShareholders Turn Down Tender Offer to Take BioCanCell Private

China-Focused Life Science Investor Acquires 37% of NovaBay for $28M

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

After the transaction, it will be NovaBay's largest shareholder with 6.6 million shares, 37% of the total. Source: BioSpace

Continue ReadingChina-Focused Life Science Investor Acquires 37% of NovaBay for $28M

Doctors Accuse NextSource Biotech for Hiking the Price on Key Cancer Drug Nine Times

  • Post author:Sam
  • Post published:December 27, 2017
  • Post category:BioPharma

The cost of a vital cancer drug has gone up 15-fold in four years after its new owner hiked prices on nine separate occasions. Source: BioSpace

Continue ReadingDoctors Accuse NextSource Biotech for Hiking the Price on Key Cancer Drug Nine Times

Reckitt CEO's $17B Predicament

  • Post author:Sam
  • Post published:December 26, 2017
  • Post category:BioPharma

2018 is the year for Rakesh Kapoor to show he's worth it. Source: BioSpace

Continue ReadingReckitt CEO's $17B Predicament

How This CRISPR Biotech Could Make Investors Rich

  • Post author:Sam
  • Post published:December 26, 2017
  • Post category:BioPharma

A look at a biotech company that represents a solid trend in the industry. Source: BioSpace

Continue ReadingHow This CRISPR Biotech Could Make Investors Rich

Array Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics

  • Post author:Sam
  • Post published:December 26, 2017
  • Post category:BioPharma

It appears that what Array is trying to do is focus on oncology while the new subsidiary focuses on rare diseases. Source: BioSpace

Continue ReadingArray Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics
  • Go to the previous page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.